
In November, the annual fall symposium of the German IQWIG took place. You can listen live to the presentations on the IQWIG webpage. Jaime Caro presented on international standards for the setting of ceiling prices. (24th November)
Health Economics and HTA and its role in pricing and reimbursement, pipeline and in-lisencing evaluations as well as portfolio and company valuations in the biotech and pharmaceutical sector is ever increasing. While I was searching the web for various news on the topic, I actually couldn't find a blog that offers a platform of exchange among professionals in this field around the various topics - so there we go now and I hope you enjoy the information... Cheers Ulf
No comments:
Post a Comment